Fundraising FoxMFX
7 known investors
Find your way into MFX
Sign up to see every warm intro you have to MFX
- Paths you didn't know you had: your email and LinkedIn already hold routes to the MFX team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
MFX develops the Cyto Engine, an automated bioprocessing platform that accelerates development and manufacturing of engineered cells for cell and gene therapy. The platform combines scalable bioprocessing with analytics and data tools to increase access to these therapies.
Investors · 7
Also in the syndicate · 5
Esco LifeSciencesJ.B. Ugland Venture ASLongwall VenturesPerscitusUKI2S
In the news
Frequently asked questions
- What does MFX do?
- MFX develops the Cyto Engine, an automated bioprocessing platform that accelerates development and manufacturing of engineered cells for cell and gene therapy. The platform combines scalable bioprocessing with analytics and data tools to increase access to these therapies.
- Who are MFX's investors?
- MFX's investors include Cambridge Angels group, Longwall Venture Partners LLP.